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ABSTRACT 
The1e is an approximate balance between the rising incidence of the common types of skin 
tumors and improving recognition and treatment of them. As a result, the death rate from 
primary malignant tumors of the skin in white people in the U.S. is currently stable. In 
recent years the death rate in the elderly has fallen , while it has risen in the middle-aged and 
young. As a result, the mean 3ge of death has declined and the loss of expected life from these 
tumors has increased. Currently, about two-thirds of the deaths are due to malignant 
melanoma. 
The incidence of malignant melanoma reported 
by the large and long established population-based 
cancer registries in t he U.S.-Upper New York 
Sta te [1], Connecticut [2], Texas [3 ]-is rising. 
The incidence also rose between the Second Na-
1 tiona! Cancer Survey in 1947- 1950 [4] and the 
current Third Survey [5 ]. Upper New York State 
1 has provided data on the trend of other skin 
cancers (Table I). These suggest t hat the incidence 
of all the common primary malignant tumors of 
skin is increasing, and that the reported in crease 
' in the malignant melanomas is not simply a 
transfer of cases due to better reporting. 
Basal cell carc inomas seldom metastasize or 
cause death [6 ], while in recent years the propor-
tion of squamous cell carcinomas that have caused 
death is under 1 percent [7 ]. There has been a 
rapid improvement in the sensit ivity of patients 
I a_nd the alertness of physicians, so that the propor-tiOn of malignant melanomas recognized early has 
, improved substantially (Table II). The survival 
rate in malignant melanomas has a lso improved ! substantially (Table II). 
The death rate from all primary malignant 
tumors of skin is about 30 per million in white 
males and 20 per million in white fema les-pro-
ducing an expected 5,200 deaths in the white U.S . 
· population in 1971. The American Cancer Society 
re ports, " These ra tes show slight fluctuations from 
year to year, but overall there is no change in both 
sexes." [9) The present experience of the U.S. 
white population from malignant tumors of skin 
represents a balance of opposing forces which are 
not stable. The following paper presents published 
and unpublished data on the reported mortality 
over the years to provide background for more 
detai led statistical and clinical studies. 
DATA 
Analysis has been made of the mortality data for 
the U.S . white population for the single years 1945, 
Received July 12, 1972; accepted for publication 
August 22, 1972. 
* From the Department of Epidemiology and Interna-
tional Health, School of Public Health and Community 
Medicine, University of Washington, Seattle, Washing-
ton 98105. 
445 
1950, 1955, and 1960. These are derived from 
Haenszel 's series (which goes back to 1930) [10], 
and from the U.S. Vital Statistics for 1960 [ll). 
Single years ' data have also been analyzed for 
1964- 1968, t he last five years that are available 
[11]. Unpublished tabulation of deaths from ma-
lignant melanoma and other skin tumors by age 
and sex a lso have been used. t 
Death rates vary widely between age groups, and 
the morta li ty of a complete population, or even of 
broad age groups within it, are a function both of 
the death rates specific to particular ages and to 
the proportion of the different age groups within a 
populat ion. T hese age distributions change with 
time and are different for men and women. If 
comparisons are to be made between the sexes, or 
between different periods of time, the actual 
populations must be adjusted to a standard popu-
lation which is the same throughout the compari-
sons. The standard Un ion Internationale Contre le 
Cancer " European" population [12] represents a 
typical developed country. It has been used in 
many studies of data from cancer registries, and 
faci litates international comparisons. It has been 
used for the adjustments through this study, 
except for the New York incidence data . 
The age at which death from tumors of skin 
occurs has changed. The consequences of a death 
are different at different ages. To provide a meas-
ure of this, the loss of expected life due to the 
deaths have been ca lculated, using the U.S. life 
tables [13 ]. 
OBSERVATIONS 
The number of deaths, the death rates per 
million, and the adjusted death rates per million 
from all types of primary malignant tumor of skin 
for the period 1945- 1968 are shown in Table ill. 
The number of deaths has tended to rise, largely 
due to the increase in the population. The death 
rate in males fe ll between 1945 and 1950, and then 
has remained steady. The female death rate has 
remained fairly constant throughout the period. 
Over the years the proportion of elderly people in 
t National Center for Health Statistics: Unpublished 
data, 1972. 
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TABLE I 
Adjusted incidence rates* per million for malignant 
m elanoma and other skin cancer by sex- Upper New 
York State 1941-67 
194 1- 1949- 1959- 1963- 1967 43 51 61 65 
Male 
Malignant melanoma 122 153 245 294 337 
Other sk in cancer 252 293 367 427 490 
- - - - -
Total sk in cancer 374 446 612 721 827 
Female 
Malignant melanoma 177 178 238 286 293 
Other ski n cancer 157 191 241 286 340 
- - - - -
Total skin cancer 334 369 479 572 633 
* Adjusted to the U.S. 1940 populat ion. Data from [1 j 
and unpublished State of New York Cancer Control 
Bureau. 
TABLE II 
Percentage of patients presenting with malignant 
melanoma still localized, and relative suruiual rate.* 
End Results Group 1940-49 to 1965-69t 
1940- 49 1950-59 1960-64 1965-69 
Percentage of malignant 52% 62% 69% 73% 
melanoma localized 
at the time of pri• 
mary treatment 
Relative survival rate* 
3-year 49% 63% 69% 74 % 
5-year 41% 56% 63% -
10-year 33% 52% - -
* The observed percentage of survivors as a ratio of 
the expected percentage of survivors of the same age 
and sex at the time. 
t [8]. 
the population, and the proportion of children, 
have both increased relative to those in the middle 
years, and in 1945 there were numbers of men out 
of the country. Adjusting for a ll these changes in 
the population at risk, the death rates from total 
skin tumors declined from 1945 to 1955, and since 
then have remained stable with only minor fluctu-
ations. 
This stability has been produced by a steady 
decline in the death rate over the age of 65 in both 
sexes (Figure), and an increase in the death rate at 
ages 45-64 and 15- 44. This latter trend appears to 
be levelling off, but insufficient years have been 
reported so far to be sure of this. As a consequence 
of these changes the mean age at which death 
occurred fell by about ten years between 1945 and 
1960, and has since remained fairly stable (Table 
IV) . The average patient dying of a tumor of skin is 
losing a greater number of years of potential 
life-greater for women than for men because of 
their lower death rates from other causes (Table 
IV) . The ann~al loss of expected life in a popula-
tion group (the product of the death rate and the 
years of life lost by those dying) has risen consider-
ably since World War II in spite of t he decline in 
the death rate (Table IV) . In 1950, after the 
disturbing effects of World War II were over, 38 
percent of the total years of life lost due to deaths 
from tumors of skin in males were in the working 
years 15-64. In fema les the corresponding figure in 
1950 was 36 percent. In 1968, the latest yea r 
ava ilable, the percentage was 46 percent in males 
and 44 percent in females. Death from primary 
tumors of the skin is thus increasingly a problem of 
the young and middle-aged. 
In Tab le V the latest available data are given for 
deaths due to malignant melanoma and other skin 
tumors. Melanomas cause the majority of the 
deaths, and the mean age of those dying from them 
is younger than that of those dying from other skin 
tumors. In consequence, the loss of years of poten-
tia l life, particularly in t he working years to age 65, 
is primarily due to melanomas. 
TABLE III 
Deaths, death rates per million, and adjusted death rates per million* from all primary malignant tumors of sl1 in. , 
by sex. U.S . whites, 1945- 1968 
1945 !950 1955 1960 1964 1965 1966 1967 1968 
Male 
Deaths 2,009 1,941 2,021 2,254 2,592 2,594 2,583 2,693 2,522 
Death rate 40 29 28 29 31 31 31 32 29 
Death rate (adjusted) 54 41 36 37 40 40 39 40 37 
Female 
Deaths 1,272 1,388 1,465 1,577 1,717 1,807 1,790 1,832 1.709 
Death rate 20 20 20 20 20 21 20 21 19 
Death rate (adjusted) 32 27 24 22 23 23 22 23 21 
• All ages: rates adjusted to the same age d istribu t ion in each year and sex using the standard UICC "European" 
population. 
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FIGUHE. Trend of mortality in the white population 
of the U.S. from all primary tumors of skin combined by 
sex and broad age groups. 
DISCUSS ION 
Artefacts of death certifi cation. The interpreta-
tion of trends in series of statistical data involves 
the determination as to whether the changes are 
due to variation in t he certifying practices of 
physicians, to the way in whi ch the data are 
handled statistically, or to genuine va riat ions in 
the incidence of morta li ty. For the total group of 
primary malignant tumors of skin combined, there 
has been no substantial change in the Interna-
tional Statistical Classificat ion since 1945. The 
observed changes in the death rate could have been 
produced by the progress ive elimination of a large 
group of deaths, particu lar ly in those of the 
younger ages, which were miscert ifi ed in the early 
part of the period under study. There seems no 
reason why this should have occurred. Equally, 
there could be a progressive increase in the number 
of erroneous certifications to primary malignant 
tumors of the skin, again particularly in the young, 
of deaths due to other causes. As before, t here 
seems no reason to suppose that this has hap-
pened. The recognition of death due to the meta-
static sp read of a primary skin tumor is not often 
difficult nor likely to be frequently confused with 
anything else. Refined pathologic study has be-
come more com mon and the rise, part icularly in 
the young, has been in the number of patients 
certified as dying of primary mal ignant melanoma 
of skin . There is evidence that this is not a simple 
substitution of a more precise diagnosis [17 ], but 
TABLE !V 
Mean age at death of patients dy ing of primary tu.mors of shin, and annual loss of expected years of life per million. 
l popu.lation from these deaths. U.S. whites, male and female. 1945- 60 at (iue-year intervals. and single years 1964- 68 
J 1945 1950 1955 1960 1964 1965 1966 1967 1968 
Male 
Mean age adjusted* 74 69 66 65 63 64 64 64 63 
Female 
Mean age adjusted 75 69 65 64 63 62 62 61 62 
Male 
Annual loss of ex- 584 561 570 609 689 672 654 710 642 
pected years of life 
per million popula· 
t i ont 
Femal e 
' Annual loss of ex- 395 454 472 461 481 509 491 510 463 
pected years of life 
per million popula-
tion 
* To UICC standa rd populat ion. 
t Lost expected years of life calcu lated from 1968 life tables. This is conservative, as the tendency is for the gen-
era l death rate to slowly decline. The use of the 1949-51 U.S. whi te ma le life tables fo r the 1945 experience reduces 
the estimated loss from 584 to 577 years. Hence the estimated loss of 1945 shown above is based on lower death 1
rates than actually occurred, and the real ellperience of those surviving in to the 1970s and 1980s may well be better 
1fhan t he 1968 data suggest. Both of these effects wi ll tend to reduce the increase in the loss of years of li fe with 
time. The method for calculating the years of life lost is given in standard textbooks, e.g. , [14 ]. 'T., the total years of 
life lived after age x, is sometimes referred to as the stationary population. 
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TABLE V 
Deaths, death rates, mean age at death, and years of life 
lost from malignant melanomas and other skin tumors 
by sex. U.S. whites 1967-68 
Male Female 
Number of deaths per year• 
Melanoma 1,629 1,219 
Other Skin Tumors 979 552 
Death rate per milliont 
Melanoma 23 15 
Other Skin Tumors 15 7 
Mean age at death 
Melanoma 57 57 
Other Skin Tumors 72 72 




Loss betwee n 15- 64 278} 190} years of age 428 335 
Loss 65 & over due to 150 145 
earlier deaths 
Loss from deaths 65 & 70 55 
over 
Total loss 498 390 
Other Skin Tumors 
Loss between 15-64 
46} 29} years of age 89 58 
Loss 65 & over due to 43 29 
earlier deaths 
Loss from deaths 65 & 86 40 
over 
Total loss 175 98 
• Mean of the two years. !CD numbers 190, 191 for 
1967 ; 172, 173 for 1968. The numbers changed but for 
these tumors the classification scarcely altered [15, 16]. 
t All rates, means, and estimates of loss based on 
rates adjusted to the UICC standard population. 
-· 
the data presented here do deal with the totality of 
skin tumors. 
Conclusion. The fai lure of t he mortality rate 
from primary skin tumors to decline in the face of 
the improvement in their treatment suggests that 
the indication from the cancer registries is real, 
and that the incidence of skin tumors, particularly 
the melanomas , is rising in the U.S. white popula-
tion. There is ev idence from studies of the mortal-
ity changes that this is a cohort phenomenon [10, 
17] suggesting that the new incidence rates are due 
to progressive changes in the characteristics of the 
life-long behavior of groups of people rather than of 
changes affecting the complete population at the 
same time. The deterioration in the position of the 
middle -aged and the young since World War II has 
now been halted, but substantial improvements in 
rapidity of diagnosis and treatment of the melano-
mas will be needed if the position is to be restored. 
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